References
- Carruther A, Carruthers J (1998) Clinical indications and injections technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg 24:1189-1194 https://doi.org/10.1111/j.1524-4725.1998.tb04097.x
- Hankins CL, Strimling R, Roger GS (1998) Botulinum A toxin for glabellar wrinkles. Dose and response. Dermatol Surg 24:1181-1183 https://doi.org/10.1111/j.1524-4725.1998.tb04095.x
- Bulstrode NW, Grobbelaar AO (2002) Long-term prospective follow-up of botulinum toxin treatment for facial rhytides. Aesthetic Plast Surg 26:356-359 https://doi.org/10.1007/s00266-002-2047-1
- Sarrabayrouse MA (2002) Indication and limitations for use of botulinum toxin for the treatment of facial wrinkles. Aesthetic Plast Surg 26:233-238 https://doi.org/10.1007/s00266-002-2030-x
- Jones OM, Brading AF, Mortensen NJ (2004) Mechanism of action of botulinum toxin on the internal anal sphincter. Br J Surg. 91:224-228 https://doi.org/10.1002/bjs.4394
- Yoon HC (2002) How to use botulinum toxin for treatment. Future Publishing, Busan
- Wieder JM, Moy RL (1998) Understanding botulinum toxin: surgical anatomy of the frown, foreahead, and periocular region. Dermatol Surg 24:1172-1174 https://doi.org/10.1111/j.1524-4725.1998.tb04093.x
- Edward Ellis III, Zide MF (1995) Surgical approaches to the facial skeleton. Wolters Kluwer, Philadelphia
- Matarasso SL (1998) Complications of botulinum A exotoxin for hyperfunctional lines. Dermatol Surg. 24:1249-1254 https://doi.org/10.1111/j.1524-4725.1998.tb04106.x
- Benedetto AV (1999) The cosmetic uses of botulinum toxin type A. Int J Dermatol. 38:641-655 https://doi.org/10.1046/j.1365-4362.1999.00722.x
- Carruthers J, Carruthers A. (1991) Botulinum toxin use on glabellar wrinkles. Presented at the annual meeting of the American Society for dermatologic surgery Orlando Florida. 13-17 March. 1991.
- Carruthers JD, Carruthers JA (1992) Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 18:17-21 https://doi.org/10.1111/j.1524-4725.1992.tb03295.x
- McCurdy JA Jr (1990) Cosmetic surgery of Asian face. Thieme Medical Publishers, New York
- Price J, O'Day J (1993) A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin. J Clin Neuroophthalmol 13:67-71.
- Le Louarn C (2001) Botulinum toxin A and facial lines: the variable concentration. Aesthetic Plastic Surgery 25:73-84 https://doi.org/10.1007/s002660010100
- Cheng CM, Chen JS, Patel RP (2006) Unlabeled uses of botulinum toxins: a review, part 1. Am J Health Syst Pharm 63:145-152 https://doi.org/10.2146/ajhp050137
- Cheng CM, Chen JS, Patel RP (2006) Unlabeled uses of botulinum toxins: a review, part 2. Am J Health Syst Pharm 63:225-232 https://doi.org/10.2146/sp/06001
- Eisenberg E (2003) Diagnosis and treatment of recurrent aphthous stomatitis. Oral Maxillofac Surg Clin North Am 15:111-122 https://doi.org/10.1016/S1042-3699(02)00070-5
- Yang TY, Jang TY (2009) The value of local botulinum toxin A injection in the treatment of the pain of aphthous ulcer. Eur Arch Otorhinolaryngol 266:445-448 https://doi.org/10.1007/s00405-008-0756-z
- Leviton A (1978) Epidemiology of headaches. In: Schoenberg BS (ed) Advances in Neurology. Raven Press, New York
- Borodic GE, Acquadro M, Johnson EA (2001) Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects. Expert Opin Investig Drugs 10:1531-1544 https://doi.org/10.1517/13543784.10.8.1531
- Tan EK, Jankovic J (2000) Treating severe bruxism with botulinum toxin. J Am Dent Assoc 131:211-216 https://doi.org/10.14219/jada.archive.2000.0149
- Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin FO, Bayik Y (2005) Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 25:604-611 https://doi.org/10.1007/s00296-004-0485-6
- Wheeler AH, Goolkasian P, Gretz SS (2001) Botulinum toxin A for the treatment of chronic neck pain. Pain 94:255-260 https://doi.org/10.1016/S0304-3959(01)00358-X
- Cheshire WP, Abashian SW, Mann JD (1994) Botulinum toxin in the treatment of myofascial pain syndrome. Pain 59:65-69 https://doi.org/10.1016/0304-3959(94)90048-5
- Binder WJ, Blitzer A (2003) Treatment of migraine headache with botulinum toxin type A. Facial Plast Surg Clin North Am 11:465-475 https://doi.org/10.1016/S1064-7406(03)00076-2
- International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache classification committee of the International Headache Society. Cephalalgia 7:1-96 https://doi.org/10.1046/j.1468-2982.1987.0701001.x
- Okeson JP (2008) The classification of orofacial pains. Oral Maxillofac Surg Clin North Am 20:133-144 https://doi.org/10.1016/j.coms.2007.12.009
- Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM (2000) Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 123:669-676 https://doi.org/10.1067/mhn.2000.110960
- Freund B, Schwartz M, Symington JM (1999) The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 57:916-920 https://doi.org/10.1016/S0278-2391(99)90007-1
- Archana MS (2016) Toxin yet not toxic: botulinum toxin in dentistry. Saudi Dent J 28:63-69 https://doi.org/10.1016/j.sdentj.2015.08.002
- Lu DW, Lippitz J (2009) Complications of botulinum neurotoxin. Dis Mon 55:198-211 https://doi.org/10.1016/j.disamonth.2009.01.001
- Niamtu J 3rd (2003) Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments. J Oral Maxillofac Surg 61:317-324 https://doi.org/10.1053/joms.2003.50069